Dr. Adams on Combinatorial Approaches in Triple-Negative Breast Cancer

Dr. Adams on Immunotherapy in Triple-Negative Breast CancerПодробнее

Interview with Dr. Sylvia Adams on Possible Triple Negative TreatmentПодробнее

Breast Cancer Immunotherapy with Dr. Sylvia Adams and Victor Ty, BSN, RNПодробнее

New technology allows important discovery in triple negative breast cancerПодробнее

Dr. Sylvia Adams on Tumor-Infiltrating Lymphocytes in Triple Negative Breast CancerПодробнее

The importance of a biomarker-directed approach in triple-negative breast cancerПодробнее

Copy of Dr. Adams on Immunotherapy in Triple-Negative Breast CancerПодробнее

Dr. Adams on Whether Prior Lines of Therapy Impact Response to Immunotherapy in TNBCПодробнее

Are combination approaches the way forward for treating patients with triple-negative breast cancer?Подробнее

Cancer awareness I have BREAST CANCER / Chemotherapy ROUND 1 CYCLE 1-4/Triple negative Breast CancerПодробнее

Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancerПодробнее

Personalizing approaches in early-stage TNBCПодробнее

Dr. Sylvia Adams: Discussing prevention of metastasis in women with early breast cancer - part 2Подробнее

Developments In the Treatment of Metastatic Triple Negative Breast Cancer with Dr Sylvia AdamsПодробнее

Treating Triple Negative Breast CancerПодробнее

Dr. Bardia on Sacituzumab Govitecan in Triple-Negative Breast CancerПодробнее

Dr. Joyce O’Shaughnessy on Promising Agents in Triple-Negative Breast CancerПодробнее

Dr. Yee on Neoadjuvant Therapy for Triple-Negative Breast CancerПодробнее

Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West OncologyПодробнее